Delivery Order SPE2DB22D1103-SPE2DB24FTDR3
Award Date 1/9/24
Potential Completion Date 1/10/24
Potential Value $28K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,172.90 firm-fixed-price delivery order is for the supply of ZORTRESS 1 MG TABLET UD 60S, a pharmaceutical product. The contract has an ultimate completion date of May 30, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
- This federal contract award, with ID SPE2DB22D3009|SPE2DB25FAT21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Zortress 1 mg tablet units, valued at $18,573.23. It is a Firm Fixed Price Delivery Order contract with a completion date of March 12, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,184.09 Firm Fixed Price Delivery Order contract is for the supply of ZORTRESS 1 MG TABLET UD 60S, a pharmaceutical product. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,123.89 firm fixed-price delivery order is for the pharmaceutical product ZORTRESS 0.5 MG TABLET UD 60S, with a period of performance through July 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,803.97 firm fixed-price delivery order is for the supply of Zortress 0.75 mg tablet medication, with a period of performance ending on July 9, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,003.90 firm fixed-price delivery order is for the supply of the medication Zortress 0.25 mg tablet. The contract has an ultimate completion date of July 10, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,564.87, is for the delivery of Zortress 0.75 mg tablets. It is a firm-fixed price delivery order contract with a completion date of March 27, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, with the ID SPE2DB22D3009|SPE2DB25FAN26, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Zortress 0.5 mg tablets, a pharmaceutical product, with a ceiling value of $15,074.60 and a completion date of January 10, 2025. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare...
- This federal contract award is for the delivery of ZORTRESS 0.5 MG TABLET UD 60S pharmaceutical products, valued at $2,390.04, to the Defense Logistics Agency (DLA). The contract is a Firm Fixed Price Delivery Order, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract has an ultimate completion date of May 29, 2025 and is not a set-aside award. Amerisourcebergen Drug Corp holds a larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4556351812 - ZORTRESS 0.5 MG TABLET UD 60S. The contract, valued at $14,738.90, was awarded on February 23, 2022, with a completion date of February 24, 2022. The contract is a Delivery Order under a Firm Fixed Price arrangement. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a...